Multiplex Assay Kit for S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay)

S100-A1; S100A1; S100-Alpha; S-100 Protein; S-100 protein subunit alpha; S-100 protein alpha chain

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 87-105 96
EDTA plasma(n=5) 78-94 84
heparin plasma(n=5) 82-97 87
sodium citrate plasma(n=5) 79-101 88

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-101% 86-94% 98-105% 86-94%
EDTA plasma(n=5) 83-97% 83-90% 85-92% 96-105%
heparin plasma(n=5) 95-103% 87-104% 99-105% 79-98%
sodium citrate plasma(n=5) 91-105% 96-105% 94-103% 80-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:S100) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Brain Research Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats ScienceDirect: S0006899311008663
J Exp Neurosci A New Technique for Collection of Cerebrospinal Fluid in Rat Pups PubMed: 26056488
PLoS One Regulation of Nutritional Metabolism in Transition Dairy Cows: Energy Homeostasis and Health in Response to Post-Ruminal Choline and Methionine pubmed:27501393
brain research Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. pubmed:28238669
КиберЛенинка Levels of neurotropic autoantibodies in patients with schizophrenia article:n
Biomed Research International Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway Pubmed:29770336
Metabolic Brain Disease Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms Pubmed: 30421246
ВОЗМОЖНОСТЬ ПРОГНОЗИРОВАНИЯ ОСТРОЙ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В НИЖНЕЙ ЧАСТИ СПИНЫ С ИСПОЛЬЗОВАНИЕМ СЫВОРОТОЧНЫХ …
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA012Mu02 Recombinant S100 Calcium Binding Protein (S100) Positive Control; Immunogen; SDS-PAGE; WB.
RPA012Mu01 Recombinant S100 Calcium Binding Protein (S100) Positive Control; Immunogen; SDS-PAGE; WB.
PAA012Mu02 Polyclonal Antibody to S100 Calcium Binding Protein (S100) WB; IHC; ICC; IP.
PAA012Mu01 Polyclonal Antibody to S100 Calcium Binding Protein (S100) WB; IHC; ICC; IP.
LAA012Mu71 Biotin-Linked Polyclonal Antibody to S100 Calcium Binding Protein (S100) WB; IHC; ICC.
SEA012Mu ELISA Kit for S100 Calcium Binding Protein (S100) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA012Mu Multiplex Assay Kit for S100 Calcium Binding Protein (S100) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.